BROMAZEPAM — all Canadian products
24 DINs
7 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BROMAZEPAM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02177188 | APO-BROMAZEPAM | APOTEX INC | Tablet | Oral | BROMAZEPAM 6 MG | Marketed | |
| 02177161 | APO-BROMAZEPAM | APOTEX INC | Tablet | Oral | BROMAZEPAM 3 MG | Marketed | |
| 02171856 | BROMAZEPAM | APOTEX INC | Tablet | Oral | BROMAZEPAM 1.5 MG | Approved | |
| 02171872 | BROMAZEPAM | APOTEX INC | Tablet | Oral | BROMAZEPAM 6 MG | Approved | |
| 02171864 | BROMAZEPAM | APOTEX INC | Tablet | Oral | BROMAZEPAM 3 MG | Approved | |
| 02230585 | TEVA-BROMAZEPAM | TEVA CANADA LIMITED | Tablet | Oral | BROMAZEPAM 6 MG | Marketed | |
| 02230584 | TEVA-BROMAZEPAM | TEVA CANADA LIMITED | Tablet | Oral | BROMAZEPAM 3 MG | Marketed | |
| 02167808 | ALTI-BROMAZEPAM 1.5MG TABLETS | ALTIMED PHARMA INC. | Tablet | Oral | BROMAZEPAM 1.5 MG | Cancelled Post Market | |
| 02167816 | ALTI-BROMAZEPAM 3MG TABLETS | ALTIMED PHARMA INC. | Tablet | Oral | BROMAZEPAM 3 MG | Cancelled Post Market | |
| 02167824 | ALTI-BROMAZEPAM 6MG TABLETS | ALTIMED PHARMA INC. | Tablet | Oral | BROMAZEPAM 6 MG | Cancelled Post Market | |
| 02177153 | APO-BROMAZEPAM | APOTEX INC | Tablet | Oral | BROMAZEPAM 1.5 MG | Dormant | |
| 02220512 | BROMAZEPAM-1.5 - TAB 1.5MG | PRO DOC LIMITEE | Tablet | Oral | BROMAZEPAM 1.5 MG | Cancelled Post Market | |
| 02220520 | BROMAZEPAM-3 - TAB 3MG | PRO DOC LIMITEE | Tablet | Oral | BROMAZEPAM 3 MG | Cancelled Post Market | |
| 02220539 | BROMAZEPAM-6 - TAB 6MG | PRO DOC LIMITEE | Tablet | Oral | BROMAZEPAM 6 MG | Cancelled Post Market | |
| 02192713 | GEN-BROMAZEPAM - TAB 3MG | GENPHARM ULC | Tablet | Oral | BROMAZEPAM 3 MG | Cancelled Post Market | |
| 02192721 | GEN-BROMAZEPAM - TAB 6MG | GENPHARM ULC | Tablet | Oral | BROMAZEPAM 6 MG | Cancelled Post Market | |
| 00682314 | LECTOPAM TAB 1.5MG | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | BROMAZEPAM 1.5 MG | Cancelled Post Market | |
| 00518123 | LECTOPAM TAB 3MG | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | BROMAZEPAM 3 MG | Cancelled Post Market | |
| 00518131 | LECTOPAM TAB 6MG | HOFFMANN-LA ROCHE LIMITED | Tablet | Oral | BROMAZEPAM 6 MG | Cancelled Post Market | |
| 02192705 | MYLAN-BROMAZEPAM | MYLAN PHARMACEUTICALS ULC | Tablet | Oral | BROMAZEPAM 1.5 MG | Cancelled Post Market | |
| 02232556 | PENTA-BROMAZEPAM TABLETS | PENTAPHARM LTD. | Tablet | Oral | BROMAZEPAM 3 MG | Cancelled Post Market | |
| 02232558 | PENTA-BROMAZEPAM TABLETS | PENTAPHARM LTD. | Tablet | Oral | BROMAZEPAM 6 MG | Cancelled (Unreturned Annual) | |
| 02242152 | RIVA-BROMAZEPAM 3 MG | LABORATOIRE RIVA INC. | Tablet | Oral | BROMAZEPAM 3 MG | Cancelled Pre Market | |
| 02242153 | RIVA-BROMAZEPAM 6 MG | LABORATOIRE RIVA INC. | Tablet | Oral | BROMAZEPAM 6 MG | Cancelled Pre Market |
Browse other molecules: